For those of you who haven`t bought the NRSN IPO, the chart went exactly like this:
after NeuroSense Therapeutics Received FDA Clearance of IND for PrimeC for the Treatment of ALS today!
NeuroSense Therapeutics Ltd. (NRSN) listed yesterday only 2,000,000 shares on NASDAQ Capital at a price of $6.00.
Due to the extremely low liquidity, high volatility is expected.
I rarely see 2Mil shares float in a stock which also dropped from 6usd to 3.83usd in the pre-market right now.
I rate this a Buy!
